ChangleShuang Probiotics is a series of products jointly launched by Vision Group,
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (stock code 600332), and Quantum Hi-Tech (stock code 300149). Leveraging the brand influence and resources of its partners, the project aims to establish a solid foundation for development.
• The project is committed to building a globally recognized brand for gastrointestinal health care, offering comprehensive gastrointestinal health care products and services. Based
on research findings and technologies related to human microecology, it targets the gut
microbiota and adopts a “nourishment over treatment” approach through lifestyle interventions.
• The goal is to provide precise gastrointestinal health care solutions for individuals with suboptimal gastrointestinal health.
Individuals aged 30-50 who prioritize gastrointestinal health care
• People experiencing suboptimal health due to gut microbiota imbalances
• Those suffering from chronic conditions such as obesity, metabolic disorders (e.g., hypertension, high blood sugar, and high cholesterol), and patients recovering from severe illnesses caused by long-term gut microbiota imbalances.
Comments (0)